Estimaciones de analistas de Wall Street para LENSAR Inc (LNSR): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 2 |
| Mantener | 1 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 3 |
| Calificación media (1-5) | 0.67 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.05 | ||
| 2026-08-13 | $0.10 | $-0.17 | +160.6% |
| 2026-05-08 | $1.56 | $0.18 | +743.2% |
| 2026-03-31 | $-0.12 | $-0.07 | -80.7% |
| 2025-11-06 | $-0.31 | $-0.10 | -210.0% |
| 2025-08-07 | $-0.15 | $-0.08 | -87.5% |
| 2025-05-08 | $-2.32 | $-0.15 | -1446.7% |
| 2025-02-27 | $-1.61 | $-0.18 | -794.4% |
Ratios de valoración
| Ratio P/E | 5.44 |
| Precio / Valor contable | 5.70 |
| EV / EBITDA | 2.65 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | $24.4M | $30.5M | $26.4M | $34.5M | $35.4M | $42.2M | $53.5M | $58.4M |
| Coste de Ventas | $14.8M | $17.3M | $12.3M | $16.6M | $15.4M | $21.1M | $27.6M | $31.3M |
| Beneficio Bruto | $9.6M | $13.2M | $14.1M | $17.8M | $20.0M | $21.1M | $25.9M | $27.1M |
| I+D | $2.8M | $7.6M | $7.6M | $12.4M | $11.8M | $6.1M | $5.3M | $5.6M |
| Generales y Administrativos | $16.1M | $17.1M | $23.8M | $23.9M | $27.2M | $26.1M | $26.5M | $45.2M |
| Gastos Operativos | $18.9M | $25.9M | $32.6M | $37.5M | $40.1M | $33.3M | $36.5M | $51.7M |
| Beneficio Operativo | -$9.3M | -$12.7M | -$18.5M | -$19.7M | -$20.2M | -$12.2M | -$10.7M | -$24.6M |
| EBITDA | -$4.7M | -$8.8M | -$15.4M | -$16.8M | -$16.5M | -$10.9M | -$3.0M | -$29.8M |
| Gastos por Intereses | 0 | $2.0M | $1.3M | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$12.6M | -$14.7M | -$19.8M | -$19.6M | -$19.9M | -$14.4M | -$31.4M | -$34.3M |
| Impuestos | $20000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$12.6M | -$14.7M | -$19.8M | -$19.6M | -$19.9M | -$14.4M | -$31.4M | -$34.3M |
| BPA | $-11.77 | $-1.57 | $-1.81 | $-2.10 | $-1.96 | $-1.31 | $-2.73 | $-2.87 |
| BPA Diluido | $-11.77 | $-1.57 | $-1.81 | $-2.10 | $-1.96 | $-1.31 | $-2.73 | $-2.87 |
| Acciones en Circulación (Diluidas) | $1.1M | $10.6M | $10.9M | $9.4M | $10.2M | $11.0M | $11.5M | $12.0M |
Precio
| Precio | $7.09 |
| Capitalización | $87M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ANIK · ARAY · AVR · CRBP · CRDF · MXCT · OWLT
Explorar sector: Healthcare · Medical - Devices
Más secciones de LNSR: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones